Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:04 AM
Ignite Modification Date:
2025-12-25 @ 2:04 AM
NCT ID:
NCT00682760
Eligibility Criteria:
Inclusion Criteria:
* All patients, aged between 18 and 75 years old, had confirmed diagnoses of bilateral essential blepharospasm.
* The patients were recruited from two botulinum toxin clinics (Yonsei University and Chung-Ang University, Seoul, Korea) from October 18, 2005 until February 21, 2006.
Exclusion Criteria:
* Patients were not eligible for inclusion in the study if they
* had undergone either myectomy or neurectomy
* had received anti-spastic, muscle relaxant medication within 1 month of study entry
* had been injected previously with BTX-A within 3 months of study entry
* had any muscle disorder
* Women with positive urine pregnancy test, or who were pregnant or lactating were also excluded from the study.
* In addition, patients who had shown hypersensitivity to BTX-A previously were not eligible for inclusion in the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT00682760
Study Brief:
Protocol Section:
NCT00682760